News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Szela Mary T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Szela Mary T (CEO and President) has filed a Form 4 on TriSalus Life Sciences, Inc.|
Txns:
| Granted 172,500 options to buy
@ $11.51, valued at
$2M
|
|
| 08/15/2023 |
3
| Szela Mary T (CEO and President) has filed a Form 3 on TriSalus Life Sciences, Inc. |
| 06/16/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Disposed/sold 2,071 shares
@ $0
Disposed/sold 40,000 options to buy
@ $19, valued at
$760k
Disposed/sold 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 06/09/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/02/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 05/19/2023 |
4
| Szela Mary T (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 2,071 shares
@ $0 |
|
| 06/23/2022 |
4
| Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Szela Mary T (Director) has filed a Form 4 on Prometheus Biosciences, Inc.|
Txns:
| Granted 20,500 options to buy
@ $29.02, valued at
$594.9k
|
|
| 07/29/2021 |
3
| Szela Mary T (Director) has filed a Form 3 on Omega Therapeutics, Inc. |
| 06/23/2021 |
4
| Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $21.54, valued at
$495.4k
|
|
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/13/2021 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.58, valued at
$351.6k
|
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Sold 54,997 shares
@ $17.5784, valued at
$966.8k
Exercised 14,997 options to buy
@ $2.5005, valued at
$37.5k
Exercised 20,000 options to buy
@ $10.05, valued at
$201k
Exercised 20,000 options to buy
@ $12.37, valued at
$247.4k
|
|
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.73, valued at
$354.6k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2019 |
4
| Szela Mary T (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 50,000 options to buy
@ $0.92, valued at
$46k
|
|
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2018 |
4
| Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 30,000 options to buy
@ $11.55, valued at
$346.5k
Granted 7,583 options to buy
@ $11.55, valued at
$87.6k
|
|
| 11/08/2018 |
3
| Szela Mary T (Director) has filed a Form 3 on Kura Oncology, Inc. |
| 06/21/2018 |
4
| Szela Mary T (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 40,000 options to buy
@ $0.86, valued at
$34.4k
|
|
| 06/21/2018 |
3
| Szela Mary T (Director) has filed a Form 3 on ALIMERA SCIENCES INC |
| 02/05/2018 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.05, valued at
$201k
|
|
| 05/19/2017 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $23.8, valued at
$476k
|
|
| 05/11/2017 |
4
| Szela Mary T (CEO) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Paid exercise price by delivering 2,248 shares
@ $9.42, valued at
$21.2k
Exercised 6,632 restricted stock units
@ $0 |
|
| 12/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/01/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2016 |
4
| Szela Mary T (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 10,000 options to buy
@ $18.28, valued at
$182.8k
|
|
| 05/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|